Rancho Santa Margarita, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Blue California, an industry leader in science-driven ingredient development, announced the successful completion of a groundbreaking human clinical trial of ergothioneine. A double-blinded placebo-controlled clinical trial sponsored by Blue California has shown that ErgoActive® ergothioneine supports aspects of cognitive function, memory, and sleep in healthy elderly subjects with subjective memory complaints.

加利福尼亚州兰乔·圣玛格丽塔（Rancho Santa Margarita），2024年2月5日（环球通讯社）--科学驱动成分开发的行业领导者Blue California宣布成功完成了麦角硫氨酸的开创性人体临床试验。由Blue California赞助的一项双盲安慰剂对照临床试验表明，ErgoActive®麦角硫氨酸支持患有主观记忆障碍的健康老年受试者的认知功能，记忆和睡眠方面。

'Blue California is proud to have sponsored such an important human study,” said Linda May-Zhang, Ph.D., VP of Science and Innovation at Blue California. “We are pleased by the results showing improvements of cognitive function and ability to get to sleep in subjects consuming ErgoActive for four months.” Research has suggested that inadequate levels of ergothioneine are associated with a range of health problems, including cardiovascular disease, frailty, age-related cognitive decline, neurodegenerative diseases such as Parkinson’s disease, and dementias such as Alzheimer’s disease.

“蓝色加利福尼亚州为赞助如此重要的人类研究而感到骄傲，”蓝色加利福尼亚州科学与创新副总裁琳达·梅·张博士说。“我们对研究结果感到高兴，结果显示，服用四个月的ErgoActive的受试者的认知功能和睡眠能力有所改善。”研究表明，麦角硫氨酸水平不足与一系列健康问题有关，包括心血管疾病、虚弱、与年龄有关的认知能力下降、帕金森氏病等神经退行性疾病，和痴呆症，如阿尔茨海默氏病。

Mushroom consumption and estimated dietary ergothioneine intake have previously been associated with reduced risk of cognitive decline and potentially longer lifespan. Despite decades of preclinical research, association studies, and clinical studies conducted with mushrooms, it remained untested whether supplementation with pure ergothioneine can improve cognitive outcomes.

食用蘑菇和估计的膳食麦角硫氨酸摄入量以前与认知能力下降的风险降低和潜在的更长寿命有关。尽管对蘑菇进行了数十年的临床前研究，关联研究和临床研究，但补充纯麦角硫氨酸是否可以改善认知结果仍未经过测试。

Rigorous clinical studies were lacking. Today, Blue California has made a substantial advancement by sponsoring a double-blinded, placebo-controlled clinical study conducted at a national research institution. Sharing his insights, Robert B. Beelman, Ph.D., Professor Emeritus of Food Science and Director of the Center for Plant and Mushroom Foods.

缺乏严格的临床研究。今天，Blue California通过赞助在国家研究机构进行的双盲安慰剂对照临床研究取得了重大进展。罗伯特·比尔曼（RobertB.Beelman）博士、食品科学名誉教授、植物和蘑菇食品中心主任分享了他的见解。

Attachments

附件

Blue California successfully completes groundbreaking human clinical trial of ergothioneine.

Blue California成功完成了麦角硫氨酸的开创性人体临床试验。

Despite not being produced in the body, ergothioneine is present in nearly all human cells, suggesting its significance in supporting human health.

尽管麦角硫氨酸不在体内产生，但几乎所有人类细胞中都存在麦角硫氨酸，这表明它在支持人类健康方面具有重要意义。